The application of Spongostan in endoscopic dacryocystorhinostomy
Author: Chih-Chung Lin
Base Hospital / Institution: Taipei City Hospital, Taiwan
ePoster presentation
Abstract ID: 25-438
Purpose
Endoscopic Dacryocystorhinostomy (DCR) has become a popular surgery in the management of distal lacrimal duct obstruction. It has high success rates comparable to external DCR, with the advantage of no external scars. Spongostan is a sterile, water-insoluble, bio-absorbable sponge, which is widely used as a hemostatic material in sinus operation. The aim of this study is to evaluate the usefulness of Spongostan in endoscopic DCR surgery.
Methods
A retrospective analysis of 20 endoscopic DCR procedures operated by a single surgeon from January 2022 to December 2023 was performed. Patient demographics, clinical features, complications and outcomes were examined. Follow-up periods were 6 to 12 months.
Results
There were 16 female and 4 male included in this study and the mean age was 70.4 years old. The average follow-up duration was 10.6 months. In the 20 eyes that underwent endoscopic DCR procedures, the overall anatomical and functional success rate was 95%. The postoperative complications included nasal bleeding and discharge, periorbital ecchymosis, silicone stent dislocation and Spongostan loss. The Spongostan was supposed to prevent the postoperative massive bleeding, avoid wound adhesion, and keep the internal ostium easy to clean and patent postoperatively.
Conclusion
We conclude that the use of Spongostan over the nasal cavity in endoscopic DCR may reduce the postoperative wound bleeding and surgical adhesions. In addition, high surgical success rate is achieved due to the easy postoperative wound care.
Additional Authors
There are no additional authors to display.
